Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes and sports enthusiasts under the SiS brand name in the United Kingdom, rest of the European Union, Australia, and internationally. Its principal product range SiS GO energy powders, isotonic gels, energy bars and hydration tablets; and SiS REGO, a range of spectrum recovery products; and WHEY20, a protein product. The company sells its products through independent sports retailers, grocers, high street chains, and third-party online retailers, and international sales distributors, as well as e-commerce platform. Science in Sport plc was founded in 1992 and is based in London, the United Kingdom.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-1282-440980
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£17.28 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Science in Sport (LON:SIS) Frequently Asked Questions
What is Science in Sport's stock symbol?
Science in Sport trades on the London Stock Exchange (LON) under the ticker symbol "SIS."
How were Science in Sport's earnings last quarter?
Science in Sport PLC (LON:SIS) announced its quarterly earnings results on Wednesday, March, 21st. The company reported ($7.70) earnings per share (EPS) for the quarter, topping the consensus estimate of ($8.20) by $0.50. The company earned $15.62 million during the quarter. View Science in Sport's Earnings History.
What price target have analysts set for SIS?
1 equities research analysts have issued 1 year target prices for Science in Sport's stock. Their forecasts range from GBX 115 to GBX 115. On average, they expect Science in Sport's stock price to reach GBX 115 in the next year. This suggests a possible upside of 125.4% from the stock's current price. View Analyst Price Targets for Science in Sport.
What is the consensus analysts' recommendation for Science in Sport?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Science in Sport in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Science in Sport.
Has Science in Sport been receiving favorable news coverage?
News articles about SIS stock have trended somewhat positive recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Science in Sport earned a media sentiment score of 1.7 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
Who are some of Science in Sport's key competitors?
Some companies that are related to Science in Sport include ICC Labs (ICC), WeedMD (WMD), Delta 9 Cannabis (NINE), Biosyent (RX), Zomedica Pharmaceuticals (ZOM), Auscann Group (AC8), Probiotec (PBP), Invion (IVX), Shield Therapeutics (STX), MMJ Group (MMJ), Cipher Pharmaceuticals (CPH), Viridium Pacific Group (VIR), Indiva (NDVA), MGC Pharmaceuticals (MXC) and Amryt Pharma (AMYT).
What other stocks do shareholders of Science in Sport own?
Who are Science in Sport's key executives?
Science in Sport's management team includes the folowing people:
- Mr. Stephen N. Moon, CEO & Exec. Director
- Ms. Elizabeth J. Lake, CFO & Exec. Director (Age 51)
How do I buy shares of Science in Sport?
Shares of SIS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Science in Sport's stock price today?
One share of SIS stock can currently be purchased for approximately GBX 51.02.
How big of a company is Science in Sport?
Science in Sport has a market capitalization of £60.47 million and generates £17.28 million in revenue each year.
What is Science in Sport's official website?
How can I contact Science in Sport?
Science in Sport's mailing address is 16-18 Hatton Garden, LONDON, EC1N 8AT, United Kingdom. The company can be reached via phone at +44-1282-440980.
MarketBeat Community Rating for Science in Sport (LON SIS)
MarketBeat's community ratings are surveys of what our community members think about Science in Sport and other stocks. Vote "Outperform" if you believe SIS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SIS will underperform the S&P 500 over the long term. You may vote once every thirty days.
